Free and protein-bound tryptophan in serum of untreated patients with chronic renal failure. In fasting sera from 46 untreated patients with chronic renal failure and in 22 normal subjects, non-protein-bound tryptophan, F, was separated by pH-controlled equilibrium dialysis.
chronic renal failure. In fasting sera from 46 untreated patients with chronic renal failure and in 22 normal subjects, non-protein-bound tryptophan, F, was separated by pH-controlled equilibrium dialysis.
Total tryptophan, T, and F were measured by HPLC. Results in patients were related to gender, severity of chronic renal failure (as measured by radioisotopic glomerular filtration rate), protein intake (as measured by 24-hr urinary urea N excretion), and protein nutrition (as measured by serum concentrations of albumin and transferrin). T was subnormal in 59% ofthe patients. In seven hypoalbuminemic patients, FIT was markedly increased (approaching unity) but F was normal. In 39 non-hypoalbuminemic patients, F was again normal but FIT was often increased at glomerular filtration rates below 30 ml/min/3 m2 of height2, especially in females. T was significantly correlated with estimated protein intake (r 0.54, P = 0.0004), even though neither F nor serum protein levels were correlated with it. We conclude that the serum level of free tryptophan is well-maintained in chronic renal failure, being uninfluenced by severity of renal insufficiency, voluntary protein intake, or serum protein concentrations. On the other hand, protein-bound tryptophan varies with protein intake, decreases markedly in hypoalbuminemic patients, and also decreases in many nonhypoalbuminemic patients (especially females) when the glomerular filtration rate falls below approximately 30 ml/minl3 m2 of height2.
Tryptophan, unlike other amino acids in plasma, is largely protein-bound. Assessment of the effective circulating concentration of tryptophan therefore requires the determination of non-protein-bound tryptophan.
In chronic renal failure, total serum or plasma tryptophan is generally reduced owing to displacement of protein-bound tryptophan by other ligands that accumulate [1] [2] [3] [4] [5] . Other aspects of tryptophan levels in chronic renal failure are unclear. For example, free (that is, non-protein-bound) tryptophan in patients with uremia is reported to be high [3, 4, 6] , normal [7] , or low [8] . In cerebrospinal fluid of pre-dialysis patients, tryptophan is increased [7, 9] . In muscle of patients on continuous peritoneal dialysis, tryptophan levels may be high even though plasma free tryptophan is low, according to a preliminary report [10] . In chronically uremic rats, total plasma tryptophan is also
The possibility that tryptophan may play a role in the progression of chronic renal failure is suggested by the observation that tryptophan radicals are readily generated by oneelectron oxidation [23, 241 . However, tryptophan and some of its metabolites are effective antioxidants [25] . The importance of oxygen free radicals in the progression of renal injury has recently been stressed [26, 27] . We have reported that serum free tryptophan level is significantly correlated with rate of progression of chronic renal failure [28] , that is, higher levels are associated with faster progression, as measured by rate of decline of glomerular filtration rate. The purpose of the present study was to assess free and total tryptophan levels in untreated pre-dialysis patients.
Methods
Fasting serum (or, in preliminary studies, plasma) was obtained from 46 patients with chronic renal failure and 22 normal subjects. In patients, but not in normal subjects, whole blood was also obtained, chilled in ice, and pH was measured at 250 within 30 minutes.
Determination of free and bound tryptophan in plasma or serum The following method was modified from Rocehi et al [29] . Venous blood was drawn with minimal stasis into a 5 or 10 ml heparinized syringe, which was immediately placed in ice. Within one hour pH was measured at room temperature.
Another tube of blood was drawn and allowed to clot.
Equilibrium dialysate was prepared as follows: 0.3 ml of 6% dextran in 0.9% NaCI, adjusted to pH 7.4, was placed in a than one minute later. In order to determine whether the presence of indoxyl sulfate in these samples increased the height of the tryptophan peak, samples from 14 patients were rerun using a mobile phase consisting of acetic acid 0.2 M:isopropanol:tetrahydrofuran, 84:10:6, adjusted to pH 6.4 with triethylamine [30] . In this system, tryptophan emerged at 3.9 minutes and indoxyl sulfate emerged at 6.0 minutes. Tryptophan concentrations estimated by this alternative method were 14 4% (sEM) higher; indoxyl sulfate concentrations are to be reported elsewhere. Thus, no substantial error was introduced by the presence of indoxyl sulfate. In order to determine whether other compounds coelute with tryptophan, samples from 10 of these patients were incubated with tryptophanase (Sigma Chemicals) for 10 minutes at 37° in the presence of pyridoxal phosphate using phosphate buffer pH 8.3 [31] . The tryptophan peak disappeared (indoxyl sulfate is also destroyed by this enzyme).
Other observations on this method
We have found that: (1) recovery of tryptophan added to normal or uremic serum averages 98 1% (sEM) (N = 8); (2) protein binding is pH-dependent, particularly in the acid range (Fig. 1) ; (3) free tryptophan is stable at 4°C for at least two weeks in plasma or serum stored at 4°C; (4) heparinized plasma contains 3 1 (suM) % less tryptophan per unit volume than serum (this is probably a dilutional effect); (5) free tryptophan is 9 3 (sEM) % higher in plasma than in serum; thus, proteinbinding is only slightly reduced by heparin, contrary to Stefanini and Biggio [32] but in confirmation of Bauman and Perry [33] .
Determination of glomerular filtration rate in patients
Following an oral water load of 10 to 15 mI/kg, 100 Ci of 99mTc.,labeled diethylenetriamine-pentaacetic acid (DTPA) was injected i.v. Beginning one hour later, three timed urine collections of 30 to 40 minutes with blood samples at the beginning and end of each collection were obtained. Urinary clearance of the isotope was calculated for each period, averaged, and expressed per 3 m2 of height2 (because average normal height2 is approximately 3 m2). Height rather than surface area was used as a referent because it does not change, whereas weight does, leading to misleading inferences in some patients [28] . Estimation of protein intake in patients Twenty-four hour urinary excretion rate of urea N (UNA) was measured. Protein intake, in g/day, was estimated as 6.25 (UNA + 0.031 wt), where wt is weight in kg [34] . These calculations are based on the assumptions that these untreated patients were in N balance and had unchanging serum urea N concentration.
Other measurements in patients were performed in the Clinical Chemistry Laboratory.
Results

Hypoalbuminemic patients
Seven of 46 patients exhibited hypoalbuminemia (serum albumin 3.4 g/dl). Their data were considered separately and are displayed in detail in Table 1 , in order of increasing serum albumin concentration. Proteinuria in this group averaged 9 g/day. Serum transferrin was subnormal in five. Mean free tryptophan level, F, 11.8 4.4 tLM, was not different from normal subjects (Table 2) , but total tryptophan, T, and proteinbound tryptophan were greatly reduced, In the most severely hypoalbuminemic patient (#71), the ratio, F/T, of free to total tryptophan, 1.07, was the ratio to be expected if protein-binding were absent (because serum is approximately 93% water). In all seven, protein-bound tryptophan, B, calculated as B = (1.07 T) Data are means SD.
-F, was more reduced than was serum albumin concentration.
The explanation for this apparent reduction in the aflinity of albumin for binding of tryptophan is not apparent, although some reduction is attributable to renal failure and protein restriction (see below). Table 2 , T was considerably reduced (especially in females), compared to normal subjects. F, however, was normal. T was below the 95% confidence limit of normal (34 tM) in half of these non-hypoalbuminemic patients. Thus the ratio FIT was increased, particularly in females.
Non-hypoalbuminemic patients As shown in
Within this group of 39 patients we sought to determine which factors were important determinants of F and T. Age was not a significant predictor, nor was serum level of transferrin or albumin (although, as indicated previously, albumin is a major determinant when hypoalbuminemic patients are also considered). As shown in Table 3 and Figure 2 , protein-binding was significantly correlated (negatively) with glomerular filtration rate. T was positively correlated with estimated protein intake (Fig. 3) , which varied from 25 to 114 g/day (mean 63 22 SD g/day), but F was not (Fig. 4) .
When stepwise multiple regression was used to determine which of the measured independent variables were predictors of B, we found that estimated protein intake, glomerular filtration rate and gender were all significant predictors. The combined regression equation is: This equation predicts 48% (=r2) of the observed variation in B in these 39 non-hypoalbuminemic patients. •I Powell [35] . In the present method, the ratio of volume of serum to volume of dialysate is 10:1, so that little change in this equilibrium is expected.
In renal failure, the importance of pH control increases, since acidosis is often present. None of our patients had severe acidosis. Nevertheless, we felt it was important to maintain serum pH at its in vivo value during dialysis. Comparison of our findings in chronic renal failure patients
• with the previous studies that we have identified [3, 4, [6] [7] [8] ___________________________________ shows that our results are more similar to those of Sullivan et a! [7] than to the others. Sullivan et al [7] and Lagana et al [6] did not control pH during ultrafiltration. Sullivan et at [7] corrected
• measured values of ultrafiltrate tryptophan for measured pH of stored plasma using a standard curve. Saito et al [4] adjusted serum pH to 7.4 before ultrafiltration but did not measure pH after ultrafiltration. These patients were all on dialysis, in _____ contrast to our study and that of Sullivan et al [7] and Cernacek 0 20 40 60 80 100 1 k et a! [8] . Lagana et al [6] do not state whether or not their patients were on dialysis. Tryptophan concentration may be important in chronic renal failure for several reasons: (1) it is an essential amino acid that is not only required for protein synthesis, but also is believed to play a unique role in the regulation of protein turnover [21, [36] [37] [38] [39] [40] [41] ; (2) (Table 4) . Our results in normal subjects are comparable to these previous data.
The two methods used for measuring F, ultrafiltration and equilibrium dialysis, both have their disadvantages. pH control during ultrafiltration is difficult to achieve, even when it is carried out in a C02-containing atmosphere. The progressive rise in plasma or serum pH that usually occurs during ultrafiltration in air is probably responsible for some of the lower values for free/total tryptophan that have been reported (Table  4) . Equilibrium dialysis necessarily disturbs the equilibrium between free and bound tryptophan. The extent of the error so introduced has been considered by Chadwick, Phipps and severe disorder known as the cosinophilia-myalgia syndrome, which may or may not be caused by a specific contaminant [42] ; (4) as noted in the introduction, tryptophan metabolites exert neuropsychiatric effects; (5) in a retrospective analysis, F was significantly correlated with rate of decline of glomerular filtration rate [28] .
The present study was limited to untreated patients and therefore sheds no light on points (2), (3), or (5) . However, our observation that F is well-maintained in these patients suggests neither point (1) nor point (4) are sources of concern.
The absence of any dependence of F on protein intake over a fivefold range (Fig. 4) is surprising, since fasting concentrations of other essential amino acids are generally strongly dependent on the level of protein intake [43] [44] [45] [46] . These findings suggest that metabolic degradation of tryptophan, most of which occurs via the kynurenine pathway [21] , may be regulated differently in response to variations in protein intake than are the degradative pathways of other essential amino acids, most of which involve oxidative enzymes.
The strong dependence of T on protein intake (Fig. 3) is also surprising, particularly because there was no correlation between serum albumin concentration and protein intake (Table  3) . Thus, the apparent affinity of albumin for binding of tryptophan increases with protein intake, and conversely, if interference by organic acids (including free fatty acids) in the albuminbinding of tryptophan is invoked to explain these results, the responsible organic acids would necessarily be present at higher levels in low protein diets. This seems implausible. However, a change in as yet unidentified plasma constituents that increase or decrease the affinity of albumin for tryptophan may explain these findings. It would be of interest to vary protein intake and determine whether bound tryptophan changes.
The diminution in protein-binding of tryptophan at low levels of GFR (Fig. 2) is almost certainly attributable to competition from organic acids, derived from metabolism and retained owing to impaired tubular secretion, as has been pointed out previously [1] [2] [3] [4] [5] .
In hypoalbuminemic subjects (Table I) , a further decrease in albumin affinity for tryptophan is apparent, not explained by their protein intake or severity of renal failure. Conceivably, hyperlipidemia, which was present in most of these subjects (Table 1 ) may be responsible. Cholesterol level was correlated with FIT in this small series (r = 0.68) but triglyceride level was not. We did not measure levels of free fatty acids, which may be particularly effective in competing for binding of tryptophan [47] .
